Precigen Inc PGEN:NASDAQ

Last Price$1.34NASDAQ Previous Close - Last Trade as of 4:00PM ET 6/30/22

Today's Change-0.02(1.47%)
Bid (Size)$1.28 (1)
Ask (Size)$1.39 (85)
Day Low / High$1.30 - 1.36
Volume713.3 K

Precigen's Acute Myeloid Leukemia Treatment Candidate Gets FDA Fast Track Designation

11:04AM ET 4/04/2022 MT Newswires
Precigen (PGEN) said Monday the US Food and Drug Administration granted fast track designation to its PRGN-3006 UltraCAR-T treatment for relapsed or refractory acute myeloid leukemia.

Acute myeloid leukemia is a cancer that starts in the bone marrow, but most often moves into the blood. The fast track label is a process to expedite the review of drugs to treat serious conditions and fill an unmet medical need.

The biopharmaceutical company's shares were up almost 6.0% in recent trading.

Price: 2.41, Change: +0.13, Percent Change: +5.95